Trial intelligence / Profile preview

RINDERON-V Ointment to Prevent Severe Oral Mucositis During Radiotherapy

jRCTs071200013Completed

Start
Sep 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of Betacap in stomatitis. Primary endpoint: Grade 3 oral mucositis onset. Started Sep 2021; status: completed.

02

Drugs

Betacap
03

Conditions

stomatitis

Beyond the preview

Go deeper on jRCTs071200013.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs071200013.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call